Gainers
• Cleveland BioLabs, Inc. CBLI stock rose 18.4% to $3.73 during Friday's pre-market session.
• Reata Pharmaceuticals, Inc. RETA shares surged 5.9% to $205.50. The most recent rating by Cantor Fitzgerald, on November 20, is at Overweight, with a price target of $314.00.
• BioCryst Pharmaceuticals, Inc. BCRX stock increased by 5.0% to $2.94. According to the most recent rating by Bank of America, on November 15, the current rating is at Buy.
• Novavax, Inc. NVAX shares increased by 4.1% to $7.29.
Losers
• Intec Pharma, Inc. NTEC stock declined 31.7% to $0.32 during Friday's pre-market session.
• Titan Pharmaceuticals, Inc. TTNP stock decreased by 5.6% to $0.25.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.